COMPANY

Mozart Therapeutics

Keywords: immunology autoimmune disease autoimmune diseases

Profile checked Oct 10, 2026

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

InvestorListed in the portfolio of ARCH Venture Partners (captured Oct 12, 2026). portfolio page ↗